Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Investigational New Drugs|March 17, 2007
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumorsMartee L Hensley, Don Dizon, Felicia Derosa, et al.
Cancer|October 12, 2013
Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapySewanti Atul Limaye, Robert I Haddad, Fiona Cilli, et al.
Plos One|February 2, 2023
In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiationMichelle Jun, Harlan Pinto, Quynh-Thu Le, et al.
Cancer Chemotherapy and Pharmacology|October 16, 2012
Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potentialPatricia M LoRusso, Sarina A Piha-Paul, Monica Mita, et al.
Investigational New Drugs|May 4, 2004
Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanomaSusan Burdette-Radoux, Richard G Tozer, Reinhard C Lohmann, et al.
Seminars in Radiation Oncology|August 7, 2003
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentAndy Trotti, A Dimitrios Colevas, Ann Setser, et al.
Head & Neck|March 3, 2017
Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomesMisha Amoils, Carolyn S Lee, John Sunwoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
The Sentinel Margin: Intraoperative <i>Ex Vivo</i> Specimen Mapping Using Relative Fluorescence IntensityStan van Keulen, Naoki Nishio, Andrew Birkeland, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumoursWells A Messersmith, Michelle A Rudek, Sharyn D Baker, et al.
Head & Neck|January 17, 2014
Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancerChad Tang, Cato Chan, Wen Jiang, et al.
Pageof 14